SCHEMBL10068545

SCHEMBL10068545

COC(=O)NCCOC(c1cccc(Cl)c1)c1cc(OCC(F)(F)F)cc(C(=O)OC)c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.37
ADRB1 P08588 1/20 0.37
ADRB3 P13945 1/20 0.37
MRGPRX4 Q96LA9 4/20 0.36
HTT P42858 3/20 0.36
TSHR P16473 2/20 0.36
MAPK1 P28482 2/20 0.36
MEN1 O00255 2/20 0.36
MAPT P10636 2/20 0.36
KMT2A Q03164 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KLKB1 P03952 1/20 0.36
LMNA P02545 2/20 0.36
REN P00797 5/20 0.35
CYP3A4 P08684 2/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PPARG P37231 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10068546 0.93 HTT (0.36) ADRB1ADRB3HTTTSHRMAPK1
SCHEMBL10068722 0.89 HTT (0.40) ADRB2ADRB1ADRB3HTTTSHR
SCHEMBL10068802 0.88 KLKB1 (0.41) ADRB2ADRB1ADRB3HTTTSHR
SCHEMBL10069327 0.88 HTT (0.40) ADRB2ADRB1ADRB3HTTTSHR
SCHEMBL10068578 0.88 HTT (0.45) ADRB2ADRB1ADRB3HTTTSHR
SCHEMBL10068953 0.88 KLKB1 (0.40) ADRB2ADRB1ADRB3HTTTSHR
SCHEMBL10068771 0.88 FAAH (0.43) ADRB1ADRB3HTTTSHRMAPK1
SCHEMBL10068808 0.87 HTT (0.43) ADRB2ADRB1ADRB3HTTTSHR
SCHEMBL10068969 0.86 ADRB2 (0.39) ADRB2ADRB1ADRB3HTTTSHR
SCHEMBL10068581 0.86 ADRB2 (0.39) ADRB2ADRB1ADRB3HTTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012019428-A1 BENZOHYDROL DERIVATIVES, A PREPARATION PROCESS AND PHARMACEUTICAL USE THEREOF 上海恒瑞医药有限公司 (CN) 2012-02-16 WO disclosed